KU 415 (Lansoprazole Delayed-Release 15 mg)

Pill with imprint KU 415 is Purple / White, Capsule-shape and has been identified as Lansoprazole Delayed-Release 15 mg. It is supplied by Lannett Company, Inc..

Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for KU 415

Lansoprazole Delayed-Release

Imprint

KU 415

Strength

15 mg

Color

Purple / White

Size

16.00 mm

Shape

Capsule-shape

Availability

Rx and/or OTC

Drug Class

Proton pump inhibitors

Pregnancy Category

B - No proven risk in humans

CSA Schedule

Not a controlled drug

Labeler / Supplier

Lannett Company, Inc.

National Drug Code (NDC)

62175-0415

Inactive Ingredients

FD&C Blue No. 1, FD&C Red No. 3, gelatin, hypromellose 2910 (6 mPa.s), magnesium carbonate, mannitol, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol 6000, polysorbate 80, sodium lauryl sulfate, sodium starch glycolate type A corn, magnesium silicate, titanium dioxide, shellac, isopropyl alcohol, butyl alcohol, ammonia, alcohol, ferrosoferric oxide, aluminum chlorohydrex propylene glycol

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer